The nation of Zimbabwe has declined a major US health deal worth $367m (272 million pounds) over five years due to Washington's demand for confidential information.
This rejection became public after a government memo from December was disclosed, indicating that President Emmerson Mnangagwa believed the arrangement was "skewed".
A government spokesperson later clarified that the US was requesting biological samples for research and commercial gain while was not willing to share the benefits from future medical innovations.
"We are forced to start the challenging and unfortunate task of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had furnished more than $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for continued negotiations to secure a deal suitable to all parties so the nation's vital HIV treatment initiative can be sustained.
Wider Context
This development comes after a comparable situation in Kenya, where a high court blocked a similar deal with the US following concerns were filed about the safety of citizens' health data.
After resuming office last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
The agency had managed assistance for the US government, but Trump claimed its expenditure was "inefficient" and his administration was seeking direct bilateral agreements to enhance openness and responsibility.
Based on reports, Sixteen African countries have to date agreed to these new health pacts, constituting more than $18.3bn of fresh investment.
Details of the Declined Deal
The funds for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this cooperation would have delivered immense advantages for Zimbabwean communities, especially the 1.2 million presently on antiretroviral therapy through US-supported initiatives," Tremont added.
However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".
"Our nation was requested to surrender its biological resources and data indefinitely, with no equivalent guarantee of benefiting from any scientific breakthroughs – like new medicines or tests – that might be developed from that provided information," he stated.
"In essence, our nation would supply the raw materials for scientific discovery without any assurance that the resulting innovations would be available to our population should a new health crisis emerge."
Sovereignty and Global Health
Mangwana further noted that the US's withdrawal from the global health body and its pursuit of one-on-one deals were undermining frameworks already set up via the global organization.
Mangwana cited its Pandemic Benefit-Sharing framework created to deal with potential global health emergencies.
"This mechanism is designed to ensure that when a nation contributes its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to create them."
These objections regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We welcome continued dialogue with our American counterparts on how future co-operation might be designed in a way that respects the sovereignty and dignity of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the official position, but recommended that negotiations should continue since a large portion of the nation's Aids initiatives were funded by international support.
"If specific concerns exist, such as those involving information security or implementation frameworks, these can often be addressed through detailed discussion and negotiated safeguards," it commented.
The halted deal underscores the continuing tensions between receiving much-needed foreign assistance and safeguarding a country's data in an increasingly interconnected world.